lenalidomide has been researched along with platinum in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (platinum) | Trials (platinum) | Recent Studies (post-2010) (platinum) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 11,422 | 457 | 6,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berton-Rigaud, D; Fabbro, M; Favier, L; Lesoin, A; Lortholary, A; Mari, V; Pujade-Lauraine, E; Ray-Coquard, I; Selle, F; Sevin, E | 1 |
| Pandey, A; Patel, K; Patel, S; Sawant, K; Singh, K; Singh, R | 1 |
1 trial(s) available for lenalidomide and platinum
| Article | Year |
|---|---|
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Fallopian Tube Neoplasms; Female; Humans; Lenalidomide; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Thalidomide | 2014 |
1 other study(ies) available for lenalidomide and platinum
| Article | Year |
|---|---|
Hyaluronic acid tethered pH-responsive alloy-drug nanoconjugates for multimodal therapy of glioblastoma: An intranasal route approach.
Topics: Administration, Intranasal; Alloys; Animals; Blood-Brain Barrier; Cell Line, Tumor; Cell Survival; Dogs; Drug Liberation; Endocytosis; Glioblastoma; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Hyperthermia, Induced; Iron; Lactoferrin; Lenalidomide; Male; Mucins; Nanoconjugates; Oleic Acid; Photoelectron Spectroscopy; Phototherapy; Platinum; Rats, Wistar; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Swine | 2019 |